HIF1α stabilization in hypoxia is not oxidant-initiated

  1. Amit Kumar
  2. Manisha Vaish
  3. Saravanan S Karuppagounder
  4. Irina Gazaryan
  5. John W Cave
  6. Anatoly A Starkov
  7. Elizabeth T Anderson
  8. Sheng Zhang
  9. John T Pinto
  10. Austin M Rountree
  11. Wang Wang
  12. Ian R Sweet
  13. Rajiv R Ratan  Is a corresponding author
  1. Burke Neurological Institute, United States
  2. Regeneron Pharmaceuticals Inc, United States
  3. New York Medical College, United States
  4. InVitro Cell Research, United States
  5. Weill Medical College of Cornell University, United States
  6. Cornell university, United States
  7. University of Washington, United States

Abstract

Hypoxic adaptation mediated by HIF transcription factors requires mitochondria, which have been implicated in regulating HIF1α stability in hypoxia by distinct models that involve consuming oxygen or alternatively converting oxygen into the second messenger peroxide. Here, we use a ratiometric, peroxide reporter, HyPer to evaluate the role of peroxide in regulating HIF1α stability. We show that antioxidant enzymes are neither homeostatically induced nor are peroxide levels increased in hypoxia. Additionally, forced expression of diverse antioxidant enzymes, all of which diminish peroxide, had disparate effects on HIF1α protein stability. Moreover, decrease in lipid peroxides by glutathione peroxidase-4 or superoxide by mitochondrial SOD, failed to influence HIF1α protein stability. These data show that mitochondrial, cytosolic or lipid ROS were not necessary for HIF1α stability, and favor a model where mitochondria contribute to hypoxic adaptation as oxygen consumers.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file.

Article and author information

Author details

  1. Amit Kumar

    Neuroscience, Burke Neurological Institute, White Plains, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5017-9887
  2. Manisha Vaish

    Muscle and Metabolism, Regeneron Pharmaceuticals Inc, Tarrytown, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Saravanan S Karuppagounder

    Neuroscience, Burke Neurological Institute, White Plains, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Irina Gazaryan

    Department of Anatomy and Cell Biology, New York Medical College, Valhalla, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. John W Cave

    Neuroscience, InVitro Cell Research, Englewood, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Anatoly A Starkov

    Brain and Mind Research Institute and Department of Neurology, Weill Medical College of Cornell University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Elizabeth T Anderson

    Cornell university, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Sheng Zhang

    Cornell university, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8206-1007
  9. John T Pinto

    Department of Anatomy and Cell Biology, New York Medical College, Valhalla, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Austin M Rountree

    University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Wang Wang

    University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Ian R Sweet

    University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7565-1663
  13. Rajiv R Ratan

    Neuroscience, Burke Neurological Institute, White Plains, United States
    For correspondence
    rrr2001@med.cornell.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9081-2701

Funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Thilo Hagen

Version history

  1. Received: August 6, 2021
  2. Accepted: September 19, 2021
  3. Accepted Manuscript published: October 1, 2021 (version 1)
  4. Version of Record published: October 21, 2021 (version 2)

Copyright

© 2021, Kumar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,027
    views
  • 348
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Amit Kumar
  2. Manisha Vaish
  3. Saravanan S Karuppagounder
  4. Irina Gazaryan
  5. John W Cave
  6. Anatoly A Starkov
  7. Elizabeth T Anderson
  8. Sheng Zhang
  9. John T Pinto
  10. Austin M Rountree
  11. Wang Wang
  12. Ian R Sweet
  13. Rajiv R Ratan
(2021)
HIF1α stabilization in hypoxia is not oxidant-initiated
eLife 10:e72873.
https://doi.org/10.7554/eLife.72873

Share this article

https://doi.org/10.7554/eLife.72873

Further reading

    1. Cell Biology
    Ang Li, Jianxun Yi ... Jingsong Zhou
    Research Article

    Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disorder characterized by progressive weakness of almost all skeletal muscles, whereas extraocular muscles (EOMs) are comparatively spared. While hindlimb and diaphragm muscles of end-stage SOD1G93A (G93A) mice (a familial ALS mouse model) exhibit severe denervation and depletion of Pax7+satellite cells (SCs), we found that the pool of SCs and the integrity of neuromuscular junctions (NMJs) are maintained in EOMs. In cell sorting profiles, SCs derived from hindlimb and diaphragm muscles of G93A mice exhibit denervation-related activation, whereas SCs from EOMs of G93A mice display spontaneous (non-denervation-related) activation, similar to SCs from wild-type mice. Specifically, cultured EOM SCs contain more abundant transcripts of axon guidance molecules, including Cxcl12, along with more sustainable renewability than the diaphragm and hindlimb counterparts under differentiation pressure. In neuromuscular co-culture assays, AAV-delivery of Cxcl12 to G93A-hindlimb SC-derived myotubes enhances motor neuron axon extension and innervation, recapitulating the innervation capacity of EOM SC-derived myotubes. G93A mice fed with sodium butyrate (NaBu) supplementation exhibited less NMJ loss in hindlimb and diaphragm muscles. Additionally, SCs derived from G93A hindlimb and diaphragm muscles displayed elevated expression of Cxcl12 and improved renewability following NaBu treatment in vitro. Thus, the NaBu-induced transcriptomic changes resembling the patterns of EOM SCs may contribute to the beneficial effects observed in G93A mice. More broadly, the distinct transcriptomic profile of EOM SCs may offer novel therapeutic targets to slow progressive neuromuscular functional decay in ALS and provide possible ‘response biomarkers’ in pre-clinical and clinical studies.

    1. Cell Biology
    Simona Bolamperti, Hiroaki Saito ... Hanna Taipaleenmäki
    Research Article

    Osteoblast adherence to bone surfaces is important for remodeling bone tissue. This study demonstrates that deficiency of TG-interacting factor 1 (Tgif1) in osteoblasts results in altered cell morphology, reduced adherence to collagen type I-coated surfaces, and impaired migration capacity. Tgif1 is essential for osteoblasts to adapt a regular cell morphology and to efficiently adhere and migrate on collagen type I-rich matrices in vitro. Furthermore, Tgif1 acts as a transcriptional repressor of p21-activated kinase 3 (Pak3), an important regulator of focal adhesion formation and osteoblast spreading. Absence of Tgif1 leads to increased Pak3 expression, which impairs osteoblast spreading. Additionally, Tgif1 is implicated in osteoblast recruitment and activation of bone surfaces in the context of bone regeneration and in response to parathyroid hormone 1–34 (PTH 1–34) treatment in vivo in mice. These findings provide important novel insights in the regulation of the cytoskeletal architecture of osteoblasts.